Trial Profile
A Phase 3B Multi-Center Open-Label Study to Evaluate the Safety of Abatacept in Subjects Who Switch From Intravenous to Subcutaneous Abatacept Therapy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Abatacept (Primary) ; Pneumococcal vaccine
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms ATTUNE
- Sponsors Bristol-Myers Squibb
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 23 Mar 2012 Actual patient number is 123 according to ClinicalTrials.gov.
- 23 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.